estimated at $7 million and are payable by us. We have agreed to reimburse the underwriters for expenses relating to clearing of this offering with the Financial Regulatory' Authority in an amount up to $100,000. Option to Purchase Additional Shares We have granted an option to the underwriters, exercisable for 30 days after the